Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity Musette, P.; Brandi, M. L.; Cacoub, P.; Kaufman, J. M.; ... Reginster, J-Y 2010
add to browser selection
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years Bruyere, O.; Collette, J.; Rizzoli, René; Decock, C.; ... Reginster, J-Y 2010
add to browser selection
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M-E; Alsayed, N.; ... Reginster, J-Y 2010
add to browser selection
The International Osteoporosis Foundation: history, objectives and achievements Cooper, C.; Rizzoli, René; Reginster, J-Y 2009
add to browser selection
Post-fracture management of patients with hip fracture: a perspective Bruyere, O.; Brandi, M-L; Burlet, N.; Harvey, N.; ... Akesson, K. 2008